MIRADOR Global Hires Key Executive Karin Turturro-Iuzzini, to Further Expand Global Commercialization Consulting Services
August 19, 2021Addition Furthers MIRADOR’s Mission to Help Biopharmaceutical Companies Streamline and Advance and their Global Commercialization Strategies
DEVON, Pa.–(BUSINESS WIRE)–MIRADOR Global, a COEUS Holdings, LLC company, today announced that it has appointed a new executive to its rapidly growing team. Karin Turturro-Iuzzini is joining as VP, Global Commercial Strategy. The hire comes one year after MIRADOR Global joined the COEUS family of companies.
“We’re elated to add Karin Turturro-Iuzzini to the MIRADOR Global team,” said Chuck Peipher, MIRADOR Global Founder & Managing Partner. “Karin is certain to play a meaningful role for our growing roster of MIRADOR clients as we help them navigate the path to product approval and successful commercialization.”
In her role, Turturro-Iuzzini will utilize her decades of experience to support MIRADOR clients in early phase commercialization strategy, forecasting, asset valuation support, payer reimbursement, risk assessment and mitigation, and portfolio/product opportunity assessment and prioritization –all leading up to launch planning.
“We are very excited to have Karin join the MIRADOR team,” stated Marc Hixson, Managing Director at COEUS Holdings, LLC. “Karin’s knowledge, skill, and thoughtful approach to client relationships only further enhance the overall deep knowledge base that COEUS Holdings employees bring to each engagement.”
Karin Turturro-Iuzzini brings more than 20 years of biopharmaceutical experience to MIRADOR Global. Karin has had great success in building and leading award-winning sales teams, creating dynamic learning & development curricula, and designing and executing marketing strategies, including new product planning. Karin’s collaborative and communicative leadership has driven the success of her cross-functional teams in pre-launch, launch, and post-launch settings. Karin has enjoyed learning and working within many therapeutic areas, including oncology, hematology, rare disease, CNS, respiratory, and cardiovascular –all while keeping a patient-centric vision and approach.
About MIRADOR Global LP
Founded in 2016, MIRADOR Global LP is an international consulting practice that specializes in strategic global commercial development for specialty diseases, including rare diseases, oncology/immuno-oncology, immunology, and CNS disorders. MIRADOR Global client engagements are developed bringing together Global Marketing, Analytics, Market Access, HEOR, Medical Affairs, R&D, and other functions delivered by a team of pharmaceutical industry experts. The company provides its clients with a bio-pharma line of sight unlike any other unique to MIRADOR Global. For more visit www.miradorglobal.com.
About COEUS Holdings
Founded in 2020, COEUS Holdings, LLC and its subsidiaries form a boutique life sciences market access strategic and tactical consulting firm offering clients commercial support across the entire development spectrum. COEUS teams are singularly driven to optimize market access for pharmaceutical products. We are a multi-specialty, commercially aligned consultancy, offering a comprehensive suite of informed solutions for successful engagement with organized customers, providers, and patients. Leveraging years of collective real-world market expertise, we offer unique perspectives into clinical and business opportunities to support your brands’ position in the marketplace. For more information, please visit www.coeusholdings.com.
Contacts
Owen Murphy | 215.680.0155
[email protected]